Gamma interferon (IFN-␥) plays a critical role in the protective immune response to viral and protozoan infections (30) , which is mediated primarily by CD8 ϩ T cells (29) . In contrast, IFN-␥ enhances immunopathology in autoimmune diseases by upregulating major histocompatibility complex antigens (34) and activating macrophages (31) . One environmental trigger for autoimmune diseases is virus infection (20, 32) . Because IFN-␥ could be protective or a detriment, we investigated the function of IFN-␥ in an experimental murine model of multiple sclerosis triggered by virus infection. Intracerebral injection of Theiler's murine encephalomyelitis virus (TMEV), a picornavirus, into susceptible SJL/J mice results in virus persistence and immune system-mediated primary demyelination (26, 35, 37) . In contrast, infection of resistant C57BL/10SnJ mice results in acute encephalitis followed by virus clearance without demyelination. Because IFN-␥ may paradoxically be important in clearing virus but inducing immunopathology, we treated susceptible and resistant strains of mice with a neutralizing monoclonal antibody (MAb) to IFN-␥ prior to TMEV infection and during the initial stages of chronic demyelination.
SJL/J and C57BL/10SnJ female mice (4 to 8 weeks of age) were injected intracerebrally with 2 ϫ 10 5 PFU of the Daniel's (DA) strain of TMEV in a 10-l volume. XMG1.2, a rat immunoglobulin (IgG1) MAb specific for mouse IFN-␥ (2), and GL113, a rat IgG1 MAb specific for anti-␤-galactosidase (used as an isotype control) were purified from tissue culture supernatants by gel filtration and ion-exchange chromatography. Both preparations were Ͼ98% pure and contained Ͻ2 EU of endotoxin per mg of antibody. Antibodies were given intraperitoneally at an initial dose of 2 mg 1 day prior to virus infection (day Ϫ1) and then at 1 mg on days 7, 14, 21, and 28 following virus infection. Some animals received 2 mg on day 15 following infection and then 1 mg on days 21 and 28. Thirty-five days following infection, mice were perfused by intracardiac puncture with Trump's fixative. Detailed morphological analysis, without knowledge of treatment group, was performed by examining for the presence of gray matter inflammation, meningeal inflammation, and demyelination in each quadrant from 12 to 18 spinal cord coronal sections embedded in plastic (27) . Brains were cut into three coronal sections, embedded in paraffin, and stained with hematoxylin and eosin. The cerebellum, brain stem, hippocampus, thalamus, cerebral cortex, meninges, and corpus callosum were graded independently on a four-point scale for the presence of inflammation and necrosis (25) .
To detect virus antigen, spinal cord coronal sections from perfused animals were stored in 0.1 M phosphate buffer, rinsed VOL. 69, 1995 NOTES 7287 (22) . For isotype-specific ELISA, rabbit antibodies specific for IgG1 and IgG2a were used as described elsewhere (4). Treatment with anti-IFN-␥ enhanced the severity of demyelination in the spinal cord in SJL/J mice ( Table 1 ). All TMEVinfected SJL/J mice, whether treated with anti-IFN-␥ or control antibody, showed demyelination. However, there were more spinal cord quadrants showing demyelination in anti-IFN-␥-treated mice than in control-treated mice (P ϭ 0.03). In anti-IFN-␥-treated mice, demyelinating lesions were large and encompassed most of the spinal cord white matter. An increase in meningeal inflammation but not neuronal disease was observed in anti-IFN-␥-treated mice (Table 1) . To test the contribution of IFN-␥ to immunopathology, we began treatment on day ϩ15, when there was inflammation but minimal demyelination. More demyelination was detected in mice treated with anti-IFN-␥ beginning on day ϩ15 than in control-treated mice (P ϭ 0.03). We asked whether neutralization of IFN-␥ would convert normally resistant C57BL/10SnJ mice to susceptibility. Only 2 of 15 infected C57BL/10SnJ mice treated with control MAb showed demyelination in the spinal cord, but these demyelinated lesions were small. In marked contrast, all eight C57BL/10SnJ mice treated with anti-IFN-␥ showed severe demyelination ( No increase in total scores was observed in anti-IFN-␥-treated (SJL/J or B10) mice (day Ϫ1 or day ϩ15). However, more brain stem disease was observed for anti-IFN-␥-treated SJL/J mice (day Ϫ1 or day ϩ15) than for control-treated SJL/J mice. Severe (ϩ3) pathology (massive inflammation, necrosis, and neuronal injury) was observed in the brain stem in 5 of 5 SJL/J mice treated with anti-IFN-␥ (day Ϫ1), 5 of 7 SJL mice treated with anti-IFN-␥ (day ϩ15), but only 2 of 10 SJL/J mice treated with control antibody (P ϭ 0.01 [chi-square test using Yate's correction]).
Fewer virus antigen-positive cells were observed in the spinal cord in infected B10 mice than for infected SJL/J mice ( Table 2) . More virus antigen-positive cells per spinal cord area were observed in anti-IFN-␥-treated mice than for control-treated SJL/J (P Ͻ 0.008) or B10 (P Ͻ 0.03) mice. All virus antigen-positive cells were in the white matter. An excellent correlation (r ϭ 0.64; P ϭ 0.00003) was obtained between the number of virus antigen-positive cells per square millimeter of spinal cord with the demyelination score (Fig. 2) . Increased levels of virus-specific total antibody were observed in infected SJL/J mice compared with infected B10 mice (Fig. 3A and B) . However, no difference in the levels of virus-specific total Ig's (IgG and IgM) between anti-IFN-␥-treated and controltreated SJL/J or B10 mice was observed (Fig. 3A and B) . Treatment with anti-IFN-␥ increased the ratio of virus-specific IgG1 to IgG2a, on the basis of a fivefold increase in IgG1 without a change in IgG2a (Fig. 3C and 3D) .
Our studies and those of others (10, 19) demonstrate convincingly the critical role for IFN-␥ in resistance to Theiler's virus demyelinating disease. One of the genes controlling viral persistence maps close to the IFN-␥ locus on chromosome 10 (1). In addition, infection of inbred 129SV mice lacking an IFN-␥ receptor results in extensive primary demyelination (7). Treatment with MAbs to IFN-␥ resulted in widespread demyelination and virus antigen-positive cells in spinal cord white matter but did not produce the overwhelming neuronal central nervous system TMEV infection observed in immunosuppressed (12, 25) , T-cell-deficient athymic nude (28) or neonatal (24) mice. No deaths were observed following treatment with anti-IFN-␥, nor was there clinical or pathological evidence of encephalitis. Therefore IFN-␥ contributes primarily to resistance to chronic demyelination and virus persistence in the spinal cord.
Most studies suggest that the antiviral activity dependent on IFN-␥ is mediated by CD8 ϩ T cells (29, 36) . However, neutralization of endogenous IFN-␥ abrogates the activity of CD4 ϩ (TH1) cells following cytomegalovirus (13) and Schistosoma mansoni (33) cells play the major role in resistance to TMEV-induced demyelination. Resistant mice generate virus-specific H-2-restricted CD8 ϩ cytotoxic lymphocytes in the central nervous system (11) . Resistant mice depleted of CD4 ϩ or CD8 ϩ T cells (25) and mice deficient in ␤2-microglobulin develop demyelination (6, 18, 21) . In contrast, depletion of NK cells enhances encephalitis but not demyelination (16) . Therefore, antibody to IFN-␥ probably inhibited the effector function of protective CD8 ϩ or CD4 ϩ T cells, resulting in more demyelination in SJL/J mice and the abrogation of resistance in B10 mice.
The pathogenesis of chronic TMEV-induced demyelination has been proposed to be mediated by TH1 cells, which secrete IFN-␥, interleukin 2, tumor necrosis factor, and lymphotoxin and participate in delayed-type hypersensitivity responses (3, 8, 14, 17) . IFN-␥ promotes the differentiation of TH1 cells but inhibits TH2 cells (15) . In Leishmania infection, in which the TH1 response is protective but the TH2 response is fatal (5), IFN-␥ stimulates clearance of the protozoa and is required for the development of a TH1 response in healer strains of mice. Treatment with MAbs to IFN-␥ should have diminished demyelination if disease was mediated primarily by TH1 cells. In contrast, TMEV-infected mice treated with anti-IFN-␥ showed more demyelination and less virus clearance, similar to the results in Leishmania infection.
